Literature DB >> 23357522

The role of miRNA-29 family in cancer.

Yang Wang1, Xinwei Zhang, Hui Li, Jinpu Yu, Xiubao Ren.   

Abstract

The miRNA-29 family of microRNAs (miRNAs), including miR-29a, miR-29b and miR-29c, was recently reported to be aberrantly expressed in multiple cancers. Increasing evidence shows that the abnormal expression of miR-29 family is associated with tumorigenesis and cancer progression, making miR-29s a well-analyzed group of miRNAs in cancer research. Here, in this review we aim to provide an overview of the role of miR-29 family in the pathophysiologic changes of cancer cells and the epigenetic and immune regulation through the biological function of miR-29s.
Copyright © 2012 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23357522     DOI: 10.1016/j.ejcb.2012.11.004

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  94 in total

Review 1.  Dysregulation of microRNAs and their association in the pathogenesis of T-cell lymphoma/leukemias.

Authors:  Sho Ikeda; Hiroyuki Tagawa
Journal:  Int J Hematol       Date:  2014-02-25       Impact factor: 2.490

2.  miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.

Authors:  Rui Li; Jia Liu; Qun Li; Guang Chen; Xiaofang Yu
Journal:  Tumour Biol       Date:  2015-10-19

Review 3.  MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis.

Authors:  Keiko Mizuno; Hiroko Mataki; Naohiko Seki; Tomohiro Kumamoto; Kazuto Kamikawaji; Hiromasa Inoue
Journal:  J Hum Genet       Date:  2016-08-04       Impact factor: 3.172

4.  Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells.

Authors:  Penn Muluhngwi; Abirami Krishna; Stephany L Vittitow; Joshua T Napier; Kirsten M Richardson; Mackenzie Ellis; Justin L Mott; Carolyn M Klinge
Journal:  Cancer Lett       Date:  2016-12-13       Impact factor: 8.679

5.  miRNAs and Long-term Breast Cancer Survival: Evidence from the WHEL Study.

Authors:  Loki Natarajan; Minya Pu; Sherri R Davies; Tammi L Vickery; Sandahl H Nelson; Emily Pittman; Barbara A Parker; Matthew J Ellis; Shirley W Flatt; Elaine R Mardis; Catherine R Marinac; John P Pierce; Karen Messer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-06-11       Impact factor: 4.254

6.  Tumor-treating fields induce autophagy by blocking the Akt2/miR29b axis in glioblastoma cells.

Authors:  Eun Ho Kim; Yunhui Jo; Sei Sai; Mung-Jin Park; Jeong-Yub Kim; Jin Su Kim; Yeon-Joo Lee; Jae-Min Cho; Seo-Young Kwak; Jeong-Hwa Baek; Youn Kyoung Jeong; Jie-Young Song; Myonggeun Yoon; Sang-Gu Hwang
Journal:  Oncogene       Date:  2019-08-02       Impact factor: 9.867

7.  miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells.

Authors:  Nicola Amodio; Dina Bellizzi; Marzia Leotta; Lavinia Raimondi; Lavinia Biamonte; Patrizia D'Aquila; Maria Teresa Di Martino; Teresa Calimeri; Marco Rossi; Marta Lionetti; Emanuela Leone; Giuseppe Passarino; Antonino Neri; Antonio Giordano; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  Cell Cycle       Date:  2013-09-25       Impact factor: 4.534

8.  Down-regulation of miR-29b is essential for pathogenesis of uterine leiomyoma.

Authors:  Wenan Qiang; Zhaojian Liu; Vanida Ann Serna; Stacy Ann Druschitz; Yu Liu; Margarita Espona-Fiedler; Jian-Jun Wei; Takeshi Kurita
Journal:  Endocrinology       Date:  2014-01-01       Impact factor: 4.736

Review 9.  MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancer.

Authors:  Rui Yi; Yao Li; Fei-Liang Wang; Gang Miao; Ruo-Mei Qi; Yan-Yang Zhao
Journal:  World J Gastrointest Oncol       Date:  2016-04-15

Review 10.  MicroRNA-29b regulation of abdominal aortic aneurysm development.

Authors:  Lars Maegdefessel; Junya Azuma; Philip S Tsao
Journal:  Trends Cardiovasc Med       Date:  2013-07-18       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.